Profile
Edward Brown held various director and managing director positions in different companies such as Integer Holdings Corp., Access Closure, Inc., Tandem Diabetes Care, Inc., Embolic Protection, Inc., and Prometheus Laboratories, Inc. He was also a principal at Charles River Laboratories, Inc. and a partner at Health Evolution Management Co. LLC.
Additionally, he was a managing director at Credit Suisse First Boston Corp.
and Donaldson, Lufkin & Jenrette International.
He served as a lead independent director at Cardiovascular Systems, Inc. and was a former director at Replidyne, Inc., Prolacta Bioscience, Inc., Sleep Solutions, Inc., Angiotech Pharmaceuticals (US), Inc., and TPG Biotechnology Genpar LP.
Former positions of Edward Brown
| Companies | Position | End |
|---|---|---|
Health Evolution Management Co. LLC
 Health Evolution Management Co. LLC Investment ManagersFinance Health Evolution Management Co. LLC (Health Evolution Management) is a private equity firm founded in 2007 by David J. Brailer. The firm is headquartered in San Francisco, California. | Private Equity Investor | 05/04/2022 |
| CARDIOVASCULAR SYSTEMS, INC. | Director/Board Member | 11/11/2021 |
Angiotech Pharmaceuticals (US), Inc.
 Angiotech Pharmaceuticals (US), Inc. Pharmaceuticals: OtherHealth Technology Angiotech Pharmaceuticals (US), Inc. develops drugs for medicinal chemicals and botanical products. The company is located in North Bend, WA. | Director/Board Member | 01/06/2011 |
Prolacta Bioscience, Inc.
 Prolacta Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Prolacta Bioscience, Inc. provides specialty formulations of human milk for the nutritional needs of premature and critically ill infants. Its products include Prolact+ H2MF, Prolact+4, Prolact+6, Prolact+8, Prolact+10 and Neo20. The company was founded by Elena Taggart Medo in1999 and is headquartered in Duarte, CA. | Director/Board Member | 01/06/2011 |
| TPG Biotechnology Genpar LP | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| TANDEM DIABETES CARE, INC. | Health Technology |
| INTEGER HOLDINGS CORPORATION | Health Technology |
| Private companies | 15 |
|---|---|
Sleep Solutions, Inc.
 Sleep Solutions, Inc. Medical/Nursing ServicesHealth Services Sleep Solutions, Inc. (SSI) is a privately held diagnostic service provider for home testing and evaluation of sleep-disordered breathing, which includes the diagnosis of Obstructive Sleep Apnea (OSA). Sleep Solutions® offers physicians and their patients a fast, cost-effective, accurate and comfortable alternative to in-laboratory sleep studies. Utilizing proprietary sound analysis technology, its NovaSom® QSG® home-diagnostic system is delivered directly to the patient. | Health Services |
TPG Growth LLC
 TPG Growth LLC Investment ManagersFinance TPG Growth LLC is a Venture Capital firm, a subsidiary of TPG Capital Advisors LLC founded in 2000 by William E. McGlashan and Michael Guthrie. The firm is headquartered in San Francisco, United States with additional office in London, United Kingdom. | Finance |
Health Evolution Management Co. LLC
Health Evolution Management Co. LLC Investment ManagersFinance Health Evolution Management Co. LLC (Health Evolution Management) is a private equity firm founded in 2007 by David J. Brailer. The firm is headquartered in San Francisco, California. | Finance |
Angiotech Pharmaceuticals (US), Inc.
Angiotech Pharmaceuticals (US), Inc. Pharmaceuticals: OtherHealth Technology Angiotech Pharmaceuticals (US), Inc. develops drugs for medicinal chemicals and botanical products. The company is located in North Bend, WA. | Health Technology |
Charles River Laboratories, Inc.
 Charles River Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Charles River Laboratories, Inc. provides research models and laboratory animal support services. It offers quality research models and support services to the biomedical community. The company was founded in 1947 and is headquartered in Wilmington, MA. | Commercial Services |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Health Technology |
Access Closure, Inc.
 Access Closure, Inc. Medical SpecialtiesHealth Technology Access Closure, Inc. manufactures and distributes medical devices for cardiovascular and peripheral vascular markets. Its products include Mynx ace, Mynx grip, Mynx sealant technology and flash ostial system. The company was in founded in 2002 by Farhad Khosravi and is headquartered in Santa Clara, CA. | Health Technology |
Embolic Protection, Inc.
 Embolic Protection, Inc. Medical DistributorsDistribution Services Embolic Protection, Inc. develops proprietary filters that capture embolic material that is dislodged during cardiovascular surgery. | Distribution Services |
| TPG Biotechnology Genpar LP | |
Prolacta Bioscience, Inc.
Prolacta Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Prolacta Bioscience, Inc. provides specialty formulations of human milk for the nutritional needs of premature and critically ill infants. Its products include Prolact+ H2MF, Prolact+4, Prolact+6, Prolact+8, Prolact+10 and Neo20. The company was founded by Elena Taggart Medo in1999 and is headquartered in Duarte, CA. | Health Technology |
Replidyne, Inc.
 Replidyne, Inc. BiotechnologyHealth Technology Replidyne, Inc. is a biopharmaceutical company focused on developing and commercializing innovative anti-infective products. The company's new drug application (NDA) for its lead product, faropenem medoxomil, has been accepted for standard review by the FDA. Faropenem medoxomil is an orally available antibiotic for the treatment of community acquired infections, such as respiratory tract infections. Other development programs include higher dose/shorter course therapy, additional ndications for adults and a pediatric formulation of faropenem medoxomil. The ompany’s pipeline also includes a topical anti-bacterial product, REP8839, hich has a novel mechanism of action for addressing the major challenge of ethicillin-resistant Staphylococcus aureus (MRSA). The company also has iscovery programs directed to the inhibition of bacterial DNA replication, which could result in therapies to treat a wide range of antibiotic-resistant bacteria. The company is headquartered in Louisville, CO | Health Technology |
| Credit Suisse First Boston Corp. | Finance |
| Donaldson, Lufkin & Jenrette International | Finance |
Freedom Innovations LLC
 Freedom Innovations LLC Medical SpecialtiesHealth Technology Freedom Innovations LLC designs, manufactures, and markets prosthetic devices. The firm focuses on developing lower limb prosthetic solutions in collaboration with prosthetists and amputees. Its products include Renegade, Thrive, Pacifica, DynAdapt, Agilix, and Maverick Comfort AT. The company was founded in 2002 and is headquartered in Irvine, CA. | Health Technology |
Cardiovascular Systems, Inc.
 Cardiovascular Systems, Inc. Medical SpecialtiesHealth Technology Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN. | Health Technology |
- Stock Market
- Insiders
- Edward Brown
